TGA Approval

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial (281843)

ARTG ID

281843

ARTG Name

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

July 17, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

JANSSEN-CILAG PTY LTD

https://medical-cdn.nocode.com/drug_tga/2c82183fed833de62f3cb6a92f279154.pdf

https://medical-cdn.nocode.com/drug_tga/d6af7f3168544a3ca07d31fd1fc15ded.pdf

Ingredient Name

daratumumab

Empowering clinical research with data-driven insights and AI-powered tools.

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial (281843) - TGA 批准文号 | MedPath